Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane

Gastroenterology

Volumn 141, Issue 4, 2011, Pages

  Gierut, Jessica ^a   Zheng, Yu ^a   Bie, Wenjun ^a   Carroll, Robert E ^b   Ball Kell, Susan ^c   Haegebarth, Andrea ^a   Tyner, Angela L ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

AOM; BRK; Cancer Cell Signaling; Colon Cancer; EGF; Neoplasm; Sik; STAT3; Tumor Formation

Indexed keywords

AZOXYMETHANE; CASPASE 3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 6; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WILD TYPE;

EID: 80053587342     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.071     Document Type: Article

References (48)

1. P.M. Brauer, and A.L. Tyner Building a better understanding of the intracellular tyrosine kinase PTK6-BRK by BRK Biochim Biophys Acta 1806 2010 66 73
2. J.H. Ostrander, A.R. Daniel, and C.A. Lange Brk/PTK6 signaling in normal and cancer cell models Curr Opin Pharmacol 10 2010 662 669
3. M.S. Serfas, and A.L. Tyner Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases Oncol Res 13 2003 409 419 (Pubitemid 38166373)
4. E.Y. Siyanova, M.S. Serfas, and I.A. Mazo Tyrosine kinase gene expression in the mouse small intestine Oncogene 9 1994 2053 2057 (Pubitemid 24194173)
5. V. Vasioukhin, M.S. Serfas, and E.Y. Siyanova A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract Oncogene 10 1995 349 357
6. X. Llor, M.S. Serfas, and W. Bie BRK/Sik expression in the gastrointestinal tract and in colon tumors Clin Cancer Res 5 1999 1767 1777 (Pubitemid 29334458)
7. A. Haegebarth, D. Heap, and W. Bie The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2 J Biol Chem 279 2004 54398 54404 (Pubitemid 40053179)
8. A. Haegebarth, W. Bie, and R. Yang Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine Mol Cell Biol 26 2006 4949 4957 (Pubitemid 43955811)
9. H.L. Palka-Hamblin, J.J. Gierut, and W. Bie Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6 J Cell Sci 123 2010 236 245
10. A. Haegebarth, A.O. Perekatt, and W. Bie Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis Gastroenterology 137 2009 945 954
11. K.T. Barker, L.E. Jackson, and M.R. Crompton BRK tyrosine kinase expression in a high proportion of human breast carcinomas Oncogene 15 1997 799 805 (Pubitemid 27390132)
12. J.H. Ostrander, A.R. Daniel, and K. Lofgren Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells Cancer Res 67 2007 4199 4209 (Pubitemid 46815066)
13. B. Xiang, K. Chatti, and H. Qiu Brk is coamplified with ErbB2 to promote proliferation in breast cancer Proc Natl Acad Sci U S A 105 2008 12463 12468
14. H.Y. Irie, Y. Shrestha, and L.M. Selfors PTK6 regulates IGF-1-induced anchorage-independent survival PLoS One 5 2010 e11729
15. R.E. Schmandt, M. Bennett, and S. Clifford The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary Cancer Biol Ther 5 2006 1136 1141 (Pubitemid 44772228)
16. J.J. Derry, G.S. Prins, and V. Ray Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells Oncogene 22 2003 4212 4220 (Pubitemid 36876242)
17. P.M. Brauer, Y. Zheng, and L. Wang Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells Cell Cycle 9 2010 4190 4199
18. Y. Zheng, M. Peng, and Z. Wang Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor Mol Cell Biol 30 2010 4280 4292
19. H. Yu, D. Pardoll, and R. Jove STATs in cancer inflammation and immunity: a leading role for STAT3 Nat Rev Cancer 9 2009 798 809
20. L. Liu, Y. Gao, and H. Qiu Identification of STAT3 as a specific substrate of breast tumor kinase Oncogene 25 2006 4904 4912 (Pubitemid 44201181)
21. A.M. Weaver, and C.M. Silva Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6 Breast Cancer Res 9 2007 R79
22. P.J. Mitchell, E.A. Sara, and M.R. Crompton A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK Oncogene 19 2000 4273 4282
23. O. Ikeda, Y. Miyasaka, and Y. Sekine STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation Biochem Biophys Res Commun 384 2009 71 75
24. O. Ikeda, Y. Sekine, and A. Mizushima Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells J Biol Chem 285 2010 38093 38103
25. S. Grivennikov, E. Karin, and J. Terzic IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2009 103 113
26. J. Bollrath, T.J. Phesse, and V.A. von Burstin gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis Cancer Cell 15 2009 91 102
27. American Cancer Society American Cancer Society's Guide to Colorectal Cancer, 2011 http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/ index Accessed March 2011
28. T. Tanaka, H. Kohno, and R. Suzuki A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate Cancer Sci 94 2003 965 973 (Pubitemid 37508979)
29. R.H. Whitehead, P.E. VanEeden, and M.D. Noble Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice Proc Natl Acad Sci U S A 90 1993 587 591 (Pubitemid 23028908)
30. R.H. Whitehead, P.S. Robinson, and J.A. Williams Conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro J Gastroenterol Hepatol 23 2008 1119 1124 (Pubitemid 352019378)
31. T.P. Pretlow, and T.G. Pretlow Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 1756 2005 83 96 (Pubitemid 41781960)
32. Z. Feng, M. Cerveny, and Z. Yan The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR J Virol 81 2007 182 192 (Pubitemid 44975159)
33. W.S. Rasband ImageJ US National Institutes of Health, Bethesda, Maryland, USA 1997-2011 http://imagej.nih.gov/ij/ Accessed December 2010
34. R.P. Bird Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings Cancer Lett 37 1987 147 151 (Pubitemid 17157833)
35. S. Khare, K. Chaudhary, and M. Bissonnette Aberrant crypt foci in colon cancer epidemiology Methods Mol Biol 472 2009 373 386
36. D.R. Green, and G.I. Evan A matter of life and death Cancer Cell 1 2002 19 30 (Pubitemid 41039172)
37. Y. Hirose, N. Yoshimi, and H. Makita Early alterations of apoptosis and cell proliferation in azoxymethane-initiated rat colonic epithelium Jpn J Cancer Res 87 1996 575 582 (Pubitemid 26235547)
38. Y. Shen, G. Devgan, and J.E. Darnell Jr Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1 Proc Natl Acad Sci U S A 98 2001 1543 1548 (Pubitemid 32165535)
39. N. Yamagishi, H. Fujii, and Y. Saito Hsp105beta upregulates hsp70 gene expression through signal transducer and activator of transcription-3 FEBS J 276 2009 5870 5880
40. K. Leslie, C. Lang, and G. Devgan Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3 Cancer Res 66 2006 2544 2552
41. K.S. Chan, S. Sano, and K. Kiguchi Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis J Clin Invest 114 2004 720 728 (Pubitemid 39578762)
42. K. Kataoka, D.J. Kim, and S. Carbajal Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis Carcinogenesis 29 2008 1108 1114 (Pubitemid 351958688)
43. A. Fukuda, S.C. Wang, and J.P.T. Morris Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression Cancer Cell 19 2011 441 455
44. M. Lesina, M.U. Kurkowski, and K. Ludes Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer Cancer Cell 19 2011 456 469
45. J. Bromberg Stat proteins and oncogenesis J Clin Invest 109 2002 1139 1142 (Pubitemid 34496590)
46. U. Dougherty, A. Sehdev, and S. Cerda Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model Clin Cancer Res 14 2008 2253 2262 (Pubitemid 351559573)
47. A.R. Moser, C. Luongo, and K.A. Gould ApcMin: a mouse model for intestinal and mammary tumorigenesis Eur J Cancer 31A 1995 1061 1064
48. N. Barker, R.A. Ridgway, and J.H. van Es Crypt stem cells as the cells-of-origin of intestinal cancer Nature 457 2009 608 611